<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _________ TO __________.
COMMISSION FILE NUMBER 0-22743
VISTA MEDICAL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 94-3184035
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
5451 AVENIDA ENCINAS, SUITE A
CARLSBAD, CA 92008
(Address of principal executive offices)
(760) 603-9120
(Registrant's phone number, including area code)
INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED
TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING
THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS
REQUIRED TO FILE SUCH REPORTS) AND (2) HAS BEEN SUBJECT TO SUCH FILING
REQUIREMENTS FOR THE PAST 90 DAYS:
(1) YES [X] NO [ ]
(2) YES [X] NO [ ]
As of August 12, 1999 there were 13,695,684 shares of $.01 par value common
stock outstanding.
1
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
VISTA MEDICAL TECHNOLOGIES, INC.
Date: SEPTEMBER 7, 1999 /S/ JOHN R. LYON
------------------- -------------------------
John R. Lyon
President, Chief Executive Officer and
Director
Date: SEPTEMBER 7, 1999 /S/ ROBERT J. DE VAERE
------------------- -------------------------
Robert J. De Vaere
Vice President of Finance & Administration
& Chief Financial Officer
(Principal financial and accounting officer)
2
<PAGE>
Item 5. Not Applicable
Item 6. Exhibits and Reports on Form 8-K
A) Exhibits
*10.1 Fifth Amendment to Lease Dated April 30, 1999
10.2 Sofamor Danek letter Amendment dated April 19, 1999
*11.1 Statement Regarding Computation of Per Share Earnings
*27.1 Financial Data Schedule
B) Reports on Form 8-K
No reports on Form 8-K were filed by the Company during the three
months ended June 30, 1999.
* Previously filed.
3
<PAGE>
EXHIBIT 10.2
[MEDTRONIC LETTERHEAD]
April 19, 1999
Mr. John Lyon
Chief Executive Officer VIA FACSIMILE
Vista Medical Technologies ORIGINAL VIA COURIER
5451 Avenida Encinas, Suite A
Carlsbad, CA 92008
Dear John,
This letter will confirm our discussions of last Thursday, April 15, in which
Medtronic Sofamor Danek consents to amending those certain agreements with
Vista to change its spinal application distribution rights for the Vista
visualization systems from exclusive to non-exclusive. While our in-house
counsel is preparing the written amendment to the distribution agreement
consistent with this change, you should feel free to negotiate and enter into
other non-exclusive agreements for these rights as you see fit.
Please let me know if you have any questions on this consent. We will send
you the amendment shortly.
Sincerely,
/s/ Bob Paulson
cc: John Meslow
Ron Pickard
Bob Compton
Cliff Owens
Mike Ellwein
Shawn McCormick
Tom Ehlinger
Steve Phillips
Joe Moctezuma
